Open AccessKRAS Mutation Limits Response to Anti-EGFR Antibodies in First-Line & Previously Treated Colorectal Cancer Patients
Author(s) -
Rabiya S. Tuma
Publication year - 2008
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000326165.04476.07
Subject(s) - panitumumab , folfiri , kras , cetuximab , folfox , medicine , colorectal cancer , oncology , epidermal growth factor receptor , cancer , irinotecan , oxaliplatin